Guido N. J. Tytgat

Guido N. J. Tytgat's AcademicInfluence.com Rankings

Guido N. J. Tytgat

Medical

#1307

World Rank

#1633

Historical Rank

Gastroenterology

#13

World Rank

#13

Historical Rank

medical Degrees

Download Badge

Medical

Guido N. J. Tytgat's Degrees

PhD Gastroenterology University of Amsterdam

Why Is Guido N. J. Tytgat Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Guido N. J. Tytgat's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Helicobacter pylori in peptic ulcer disease. (1994) (1317)
Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report (2002) (1309)
Cure of duodenal ulcer associated with eradication of Helicobacter pylori (1990) (950)
Barrett's esophagus: development of dysplasia and adenocarcinoma. (1989) (883)
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. (1988) (722)
Update on the paris classification of superficial neoplastic lesions in the digestive tract. (2005) (719)
Campylobacter pyloridis-associated chronic active antral gastritis. (1988) (609)
Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. (1994) (556)
A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin‐Johnson syndrome (1997) (529)
Acute upper GI bleeding: did anything change? (2003) (395)
Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. (2002) (386)
Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones (1997) (385)
Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. (2003) (379)
Diagnosis of Helicobacter pylori infection with a new non-in vasive antigen-based assay (1999) (344)
The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. (1999) (308)
Treatment of Helicobacter pylori Infection: A Review of the World Literature (1996) (294)
Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis (1986) (269)
Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. (2001) (268)
Tumour-necrosis-factor antibody treatment in Crohn's disease (1993) (264)
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis (1999) (252)
Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population (2002) (239)
The Sydney System: Endoscopic division. Endoscopic appearances in gastritis/duodenitis (1991) (232)
Ischaemic Colitis (1984) (229)
Medical treatment of peptic ulcer disease : practice guidelines (1996) (226)
Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. (1992) (222)
Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy. (1990) (216)
Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. (2003) (216)
The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. (2003) (210)
Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia (1997) (199)
CAMPYLOBACTER-UKE ORGANISMS IN THE STOMACH OF PATIENTS AND HEALTHY INDIVIDUALS (1984) (198)
Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence (1994) (183)
Helicobacter pylori : basic mechanisms to clinical cure 2000 : the proceedings of a symposium organised by Axcan Pharma, held in Bermuda, March 26-29, 2000 (2000) (182)
Long term results of pneumatic dilation in achalasia followed for more than 5 years (2002) (180)
The Pathogenicity of Cytomegalovirus in Inflammatory Bowel Disease: A Systematic Review and Evidence-based Recommendations for Future Research (2004) (177)
Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function. (2001) (175)
The role of mdr2 P‐glycoprotein in hepatobiliary lipid transport (1997) (171)
Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. (1996) (171)
Cyclooxygenase‐2 expression during carcinogenesis in the human stomach (2002) (164)
Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa. (1994) (157)
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. (1999) (152)
Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. (1996) (150)
Is encopresis always the result of constipation? (1994) (147)
Zonal down‐regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver (2000) (145)
Regular review: treatment of Helicobacter pylori infection. (2000) (143)
Colonic transit time in constipated children: does pediatric slow-transit constipation exist? (1996) (143)
Helicobacter pylori infection and duodenal ulcer disease (1992) (141)
Collagenous sprue--an unrecognized type of malabsorption. (1970) (141)
The Stool Antigen Test for Detection of Helicobacter pylori after Eradication Therapy (2002) (141)
Placebo effect in the treatment of duodenal ulcer. (1999) (140)
Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction (2000) (136)
Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. (1999) (134)
The proximal stomach and postprandial symptoms in functional dyspeptics (2002) (130)
Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. (1988) (124)
14C-urea breath test in C pylori gastritis. (1989) (121)
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study (2000) (119)
Isolation of a potent cholesterol nucleation‐promoting activity from human gallbladder bile: Role in the pathogenesis of gallstone disease (1990) (118)
The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? (1995) (114)
Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. (1995) (113)
Time trends in gastric carcinoma: changing patterns of type and location. (1992) (109)
Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. (1997) (108)
Efficacy and safety of single‐triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study (2003) (108)
Impact of metronidazole resistance on the eradication of Helicobacter pylori. (1994) (107)
CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study. (1997) (106)
Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease. (1978) (106)
Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. (1990) (105)
THE ROLE OF INFECTIOUS AGENTS IN PEPTIC ULCER DISEASE (1993) (104)
Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis (1995) (101)
Diagnostic accuracy of fiberendoscopy in the detection of upper intestinal malignancy. A follow-up analysis. (1977) (101)
Value of brush cytology for dominant strictures in primary sclerosing cholangitis (1998) (95)
Endoscopic transmission of Helicobacter pylori. (1995) (94)
Fat absorption in bile fistula man. A morphological and biochemical study. (1971) (94)
Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens. (1996) (94)
Four years experience with short term stenting in primary sclerosing cholangitis (1999) (93)
Subtypes of intestinal metaplasia and Helicobacter pylori. (1992) (92)
Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. (2007) (91)
Endoscopic lesions in Crohn's disease early after ileocecal resection. (1988) (88)
Cholesterol nucleation‐influencing activity in t‐tube bile (1988) (88)
Campylobacter pylori and its role in peptic ulcer disease. (1990) (88)
Role of nitric oxide in gastric motor and sensory functions in healthy subjects (2002) (86)
Characterization of the reactivity pattern of murine monoclonal antibodies against wild‐type hepatitis B surface antigen to g145r and other naturally occurring “a” loop escape mutations (1999) (86)
The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females. (1997) (86)
Transient lower oesophageal sphincter relaxations—a pharmacological target for gastro‐oesophageal reflux disease? (2002) (85)
Cell type-dependent effect of phospholipid and cholesterol on bile salt cytotoxicity. (1991) (85)
Genomic Analysis Reveals Variation between Mycobacterium tuberculosis H37Rv and the Attenuated M. tuberculosis H37Ra Strain (1999) (84)
Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients. (1997) (84)
Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease. (1995) (83)
Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease (1998) (83)
Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. (1997) (82)
Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations. (1976) (81)
Expression and Activation of NF-κB in the Antrum of the Human Stomach (2000) (81)
Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value? (1995) (81)
Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis. (1997) (78)
Synthesis and transport of lipoprotein particles by intestinal absorptive cells in man. (1971) (77)
Treatment of Helicobacter pylori infection (1996) (75)
Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection. (2005) (75)
Cancer of the esophagus and gastric cardia: recent advances. (2004) (75)
Helicobacter pylori associated gastric diseases and lymphoid tissue hyperplasia in gastric antral mucosa. (2002) (74)
Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction (2005) (73)
Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 postgastrectomy patients. (1988) (72)
Guidelines for adults on self‐medication for the treatment of acute diarrhoea (2001) (71)
Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein. (1996) (70)
Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug. (1992) (69)
Model bile and bile salts accelerate mucin secretion by cultured dog gallbladder epithelial cells. (1995) (68)
Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study (1995) (67)
cagA-Positive Helicobacter pylori Populations in China and The Netherlands Are Distinct (1998) (66)
Chronology of p53 protein accumulation in gastric carcinogenesis. (1995) (66)
Helicobacter pylori and early gastric cancer. (1994) (65)
Shortcomings of the first-generation proton pump inhibitors. (2001) (65)
Etiopathogenetic Principles and Peptic Ulcer Disease Classification (2011) (63)
Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis. (1988) (62)
Prevalence and management of abdominal cramping and pain: a multinational survey (2006) (62)
Colloidal bismuth subcitrate in peptic ulcer--a review. (1987) (60)
Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis (2005) (59)
Helicobacter pylori: Causal agent in peptic ulcer disease? Conclusion (1991) (58)
Gastric metaplasia and Helicobacter pylori infection. (1993) (57)
The Presence and Mucin Histochemistry of Cardiac Type Mucosa at the Esophagogastric Junction (2004) (57)
Treatment of therapy-resistant perineal metastatic Crohn's disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2 (1998) (56)
Endoscopic therapy of esophageal cancer: possibilities and limitations. (1990) (56)
Role of endoscopy and biopsy in the work up of dyspepsia (2002) (56)
The mucosa of the gastric remnant harboring malignancy. Histologic findings in the biopsy specimens of 504 asymptomatic patients 15 to 46 years after partial gastrectomy with emphasis on nonmalignant lesions (1989) (55)
How to treat Helicobacter pylori infection--should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint. (1996) (54)
Intestinal pseudoobstruction caused by diffuse lymphoid infiltration of the small intestine. (1985) (53)
Manometry, Profilometry, and Endosonography: Normal Physiology and Anatomy of the Anal Canal in Healthy Children (1994) (53)
Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease. (1978) (52)
Effect of cholesterol nucleation-promoting activity on cholesterol solubilization in model bile. (1989) (52)
Acute pancreatitis in peritoneal dialysis and haemodialysis: risk, clinical course, outcome, and possible aetiology (2000) (52)
Dilation therapy of benign esophageal stenoses (1989) (51)
Ulcers and gastritis. (1994) (50)
Four years experience with short term stenting in primary sclerosing cholangitis. (1999) (50)
Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach. (1998) (50)
Effect of bisacodyl on the structure and function of rodent and human intestine. (1977) (50)
Evaluation of the performance of commercial test kits for detection of Helicobacter pylori antibodies in serum (1992) (50)
A placebo‐controlled trial of the 5‐HT1A agonist R‐137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia (2009) (50)
Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation. (1996) (49)
The spectrum of columnar-lined esophagus--Barrett's esophagus. (1989) (48)
Sucralfate versus cimetidine in reflux esophagitis. A single-blind multicenter study. (1987) (48)
Influence of oral 15(R)-15-methyl prostaglandin E2 on human gastric mucosa. A light microscopic, cell kinetic, and ultrastructural study. (1986) (48)
Malignant lymphoma in coeliac disease: various manifestations with distinct symptomatology and prognosis? (1994) (47)
Campylobacter pylori (1988) (46)
Helicobacter pylori and peptic ulcer disease. (1996) (46)
Agreement between endoscopic and histological gastric atrophy scores (2005) (46)
The potential diagnostic use of K‐ras codon 12 and p53 alterations in brush cytology from the pancreatic head region (1998) (45)
Effect of l-NMMA on Postprandial Transient Lower Esophageal Sphincter Relaxations in Healthy Volunteers (2000) (45)
Multivariate analysis of the risk of stomach cancer after ulcer surgery in an Amsterdam cohort of postgastrectomy patients. (1991) (45)
cagA-Positive Helicobacter pyloriPopulations in China and The Netherlands Are Distinct (2000) (45)
Efficacy of recombinant granulocyte colony‐stimulating factor (rhG‐CSF) in experimental colitis (1996) (45)
Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group. (1995) (44)
Clarithromycin-Susceptible and -ResistantHelicobacter pylori Isolates with Identical Randomly Amplified Polymorphic DNA-PCR Genotypes Cultured from Single Gastric Biopsy Specimens Prior to Antibiotic Therapy (2001) (44)
Impaired anamnestic cellular immune response in patients with Crohn's disease. (1975) (44)
Transmission of Helicobacter pylori via faeces (1993) (43)
Abnormal distribution of the interstitial cells of Cajal in an adult patient with pseudo-obstruction and megaduodenum (2002) (43)
Follow-up study of individuals with untreated Campylobacter pylori-associated gastritis and of noninfected persons with non-ulcer dyspepsia. (1988) (43)
Helicobacter pylori and peptic ulcer. (1995) (43)
Polarised interleukin 8 secretion by HT 29/19A cells. (1994) (42)
Reinfection versus recrudescence in Helicobacter pylori infection (1997) (42)
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals (2000) (42)
The proximal stomach and postprandial symptoms in functional dyspeptics. (2002) (41)
Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy (1994) (40)
Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines (2000) (40)
Ankylosing spondylitis and inflammatory bowel disease. I. Prevalence of inflammatory bowel disease in patients suffering from ankylosing spondylitis. (1978) (40)
90% cure: which anti-Helicobacter therapy can achieve this treatment goal? (1995) (40)
A patient with osteomalacia as single presenting symptom of gluten‐sensitive enteropathy (1992) (39)
Possible role of nitric oxide in visceral hypersensitivity in patients with irritable bowel syndrome (2006) (39)
Mucin secretion by the human colon cell line LS174T is regulated by bile salts. (1999) (38)
Helicobacter pylori in duodenal and gastric ulcer disease. (1995) (38)
CD 4 antibody treatment in patients with active Crohn ' s disease : a phase 1 dose finding study (38)
The role of colloidal bismuth subcitrate in gastric ulcer and gastritis. (1986) (38)
Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders – the clinical evidence (2005) (38)
Sucralfate, bismuth compounds, substituted benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer. (1984) (38)
Helicobacter pylori infection in peptic ulcer haemorrhage (2002) (38)
Treatment of Helicobacter pylori infection: an evaluation of various therapeutic trials (1994) (37)
Lack of enteral nutrition during critical illness is associated with profound decrements in biliary lipid concentrations. (1999) (36)
Prevalence of Helicobacter pylori infection in stress-induced gastric mucosal injury (2001) (36)
Peptic ulcer and Helicobacter pylori: eradication and relapse. (1995) (35)
Carcinogenesis after remote peptic ulcer surgery: the long-term prognosis of partial gastrectomy. (1995) (35)
A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved? (2002) (35)
Evidence for pooling of gastric secretions in the proximal stomach in humans using single photon computed tomography. (2002) (34)
Long-term consequences of Helicobacter pylori eradication. (1994) (34)
Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis? (2001) (34)
Intestinal metaplasia of the esophagus or esophagogastric junction: evidence of distinct clinical, pathologic, and histochemical staining features. (2002) (33)
Gastric, pancreatic, and colorectal carcinogenesis following remote peptic ulcer surgery. Review of the literature with the emphasis on risk assessment and underlying mechanism. (1988) (33)
Immunohistochemical analysis of inflammation in primary sclerosing cholangitis (1998) (33)
The only good Helicobacter pylori is a dead Helicobacter pylori (1997) (32)
Effect of loperamide on fecal output and composition in well-established ileostomy and ileorectal anastomosis (1977) (32)
Role of endogenous nitric oxide in regulating antropyloroduodenal motility in humans (2002) (32)
Assessment of Clarithromycin-Resistant Helicobacter pylori among Patients in Shanghai and Guangzhou, China, by Primer-Mismatch PCR (2002) (32)
Cell proliferation kinetics in the gastric remnant. (1985) (31)
The role of endoscopic Doppler US in patients with peptic ulcer bleeding. (2003) (31)
Necrotizing vasculitis and ulcerative colitis. (1974) (31)
Comparison of precancerous conditions: atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients (2001) (31)
Report of an Amsterdam Working Group on Barrett Esophagus (2003) (31)
Treatment of spondyloarthropathy with 5-aminosalicylic acid (mesalazine): an open trial. (2000) (31)
A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidine (2000) (30)
Use of 1H-NMR to determine the distribution of lecithin between the micellar and vesicular phases in model bile. (1990) (30)
Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration. (1982) (30)
A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule (2000) (30)
Molecular evidence for the same clonal origin of both components of an adenosquamous Barrett carcinoma. (2002) (30)
Current indications for Helicobacter pylori eradication therapy. (1996) (30)
Only four days of quadruple therapy can effectively cure Helicobacter pylori infection (1995) (30)
Is Glutamate Involved in Transient Lower Esophageal Sphincter Relaxations? (2002) (29)
Educational training workshop in Helicobacter pyloriBologna. (1998) (28)
Healing of chronic Barrett ulcers with omeprazole. (1986) (28)
Lexipafant (BB‐882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis (1996) (28)
Lack of eradication of Helicobacter pylori after omeprazole (1991) (28)
Is gastroduodenitis a cause of chronic dyspepsia? (1991) (28)
Early gastric cancer: a clinicopathologic study. (1991) (27)
Geographic Pathology of Helicobacter pylori Gastritis (2005) (27)
Primary malignant melanoma of the oesophagus (1992) (27)
Duodenal ulcer disease. (1996) (27)
Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus (2000) (26)
Immunohistochemical analysis of inflammation in primary sclerosing cholangitis. (1998) (26)
Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. (2008) (26)
Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis. (1989) (26)
Review article: topical corticosteroids in inflammatory bowel disease (1993) (26)
Mucins and calcium phosphate precipitates additively stimulate cholesterol crystallization. (1998) (25)
Update on the pathophysiology and management of gastro-oesophageal reflux disease: the role of prokinetic therapy. (1996) (25)
Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa (1991) (25)
Short report: smoking habits and the acquisition of metronidazole resistance in patients with Helicobacter pylori‐related gastritis (1993) (25)
No Helicobacter pylori, no Helicobacter pylori‐associated peptic ulcer disease (1995) (25)
The operated stomach: a premalignant condition? A prospective endoscopic follow-up study. (1984) (25)
Review article: drug therapy for reflux oesophagitis (1994) (25)
Helicobacter pylori: Causal agent in peptic ulcer disease? A Working Team Report. Introduction (1991) (25)
Therapeutic options after failed Helicobacter pylori eradication therapy. (1996) (25)
Recurrent polyps in the ileo-anal pouch or rectum in familial adenomatous polyposis. (1995) (24)
Molecular alterations in early gastric carcinomas. No apparent correlation with Helicobacter pylori status. (1999) (24)
Absence of ras gene mutations in early gastric carcinomas. (1995) (24)
Invasive Carcinoma after Endoscopic Ablative Therapy for High-Grade Dysplasia in Barrett’s Oesophagus (2003) (23)
Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis? (1998) (23)
Gallbladder bile patients with ileal Crohn's disease is markedly enriched in bile pigments and calcium (1999) (23)
Etiopathogenetic studies in a patient with Whipple's disease. (1977) (23)
Long-term prognosis after partial gastrectomy for benign conditions. Survival and smoking-related death of 2633 Amsterdam postgastrectomy patients followed up since surgery between 1931 and 1960. (1991) (23)
Treatment of Peptic Ulcer (1998) (23)
Anti-inflammatory effect of interleukin-10 in rabbit immune complex-induced colitis. (1998) (23)
Helicobacter pylori infection and duodenal ulcer disease. (1993) (23)
Review article: management of mild and severe gastro-oesophageal reflux disease. (2003) (23)
Sucralfate : from basic science to the bedside (1995) (23)
Equally high efficacy of 4, 7 and 10‐day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease (2000) (22)
An appraisal of the role of biliary phospholipases in the pathogenesis of gallstone disease. (1989) (22)
Pancreatic cancer after remote peptic ulcer surgery. (2002) (22)
H. pylori eradication (1994) (22)
Mechanism of bile salt-induced mucin secretion by cultured dog gallbladder epithelial cells. (1996) (22)
Long-term prognosis after partial gastrectomy for benign conditions (1991) (22)
Attenuation of the inflammatory response in an animal colitis model by neutrophil inhibitory factor, a novel beta 2-integrin antagonist. (1996) (21)
Are there unmet needs in acid suppression? (2004) (21)
Reduction of circulating secretory phospholipase A2 levels by anti-tumor necrosis factor chimeric monoclonal antibody in patients with severe Crohn's disease. Relation between tumor necrosis factor and secretory phospholipase A2 in healthy humans and in active Crohn's disease. (1998) (21)
Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo (2004) (21)
The neoplastic potential of columnar-lined (Barrett's) esophagus (1992) (20)
Antimicrobial Therapy for Helicobacter pylori Infection (1997) (20)
Helicobacter pylori 1990 (1991) (20)
REVIEW: Racecadotril Versus Loperamide: Antidiarrheal Research Revisited (2003) (19)
Four years experience with short-term stenting in primary sclerosing cholangitis (1999) (19)
Racecadotril versus loperamide: antidiarrheal research revisited. (2003) (19)
Treatment of gastro‐oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness? (2004) (19)
Disappearance of Mesenteric Lymphadenopathy with Gluten‐Free Diet in Celiac Sprue (1993) (19)
CD4 antibody treatment in Crohn's disease. (1992) (19)
Therapeutic investigations in primary sclerosing cholangitis (1986) (19)
Inflammatory bowel disease and the genes for the natural resistance-associated macrophage protein-1 and the interferon-Á receptor 1 (1999) (18)
The validity of the cholesterol nucleation assay. (1992) (18)
Effect of prolonged gastric distention on lower esophageal sphincter function and gastroesophageal reflux (2003) (18)
Mechanisms underlying neutrophil adhesion to apical epithelial membranes. (1996) (18)
Surveillance of familial adenomatous polyposis patients after ileorectal anastomosis or ileoanal pouch anastomosis. (1997) (18)
Previous use of non‐steroidal anti‐inflammatory drugs and anticoagulants: the influence on clinical outcome of bleeding gastroduodenal ulcers (1997) (18)
Geographical Variance in the Risk of Gastric Stump Cancer: No Increased Risk in Japan? (1991) (18)
A case of chronic oropharyngo-esophageal candidiasis with immunological deficiency: successful treatment with miconazole. (1977) (17)
Analysis of a positional candidate gene for inflammatory bowel disease: NRAMP2. (2000) (17)
Oral S(+)-Ketamine Does Not Change Visceral Perception in Health (2004) (17)
Gastric carcinoma: clinical, pathogenic, and molecular aspects. (1997) (17)
Effect of prolonged gastric distention on lower esophageal sphincter function and gastroesophageal reflux. (2003) (17)
Treatment of helicobacter pylori infection: management of patients with ulcer disease by general practitioners and gastroenterologists (1998) (16)
Endoscopic features of the columnar-lined esophagus. (1997) (16)
Quantification of cholesterol nucleation promoting activity in human gallbladder bile. (1987) (16)
Influence of corticotropin-releasing hormone on gastric sensitivity and motor function in healthy volunteers (2007) (15)
Immunoglobulins and α1‐acid glycoprotein do not contribute to the cholesterol crystallization—promoting effect of concanavalin a—binding biliary protein (1994) (15)
Cholesterol nucleation and gallstone formation. (1988) (15)
Decision-making in dyspepsia: controversies in primary and secondary care. (1999) (15)
The pronase resistance of cholesterol-nucleating glycoproteins in human bile. (1996) (14)
Production and Cellular Source of Interleukin‐8 in Ulcerative Colitis (1995) (14)
Analysis of a Positional Candidate Gene for Inflammatory Bowel Disease: NRAMP2 (1999) (14)
The role of endoscopy in pouch monitoring and pouchitis (1991) (14)
Recent developments in gastroesophageal reflux disease and Barrett's esophagus: ANNO 2012 (2012) (14)
Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases. (1995) (14)
Heterogeneity of human gallbladder mucin in bile. (1994) (13)
Levamisole in Crohn's disease--a double-blind controlled trial. (1978) (13)
Search and treat strategy to eliminateHelicobacter pylori associated ulcer disease (2001) (13)
Characterization of the cholesterol crystallization-promoting low-density particle isolated from human bile. (1996) (13)
Relation between vacA subtypes, cytotoxin activity, and disease in Helicobacter pylori-infected patients from the netherlands (1999) (13)
Mediators of mucosal inflammation: implications for therapy. (1997) (13)
Comparison of enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic acid and D,L-2,3-dimercaptopropane-1-sulfonic acid. (1998) (12)
Prospective randomized open label blinded endpoint (PROBE) trial of high versus low dose mesalazine for prevention of relapse in patients with UC in remission (2001) (12)
Recent developments in hereditary nonpolyposis colorectal cancer. (1996) (12)
No evidence for functional inactivation of wild‐type p53 protein by MDM2 overexpression in gastric carcinogenesis (1998) (12)
Anti‐CD4 Therapy Decreases Epithelial Expression of HLA‐DR Molecules in Patients with Crohn’s Disease (1995) (12)
Treatment of Helicobacter pylori Eradication Failure (1999) (11)
Helicobacter pylori: where are we and where are we going? (2000) (11)
Practical management issues for the Helicobacter pylori‐infected patient at risk of gastric cancer (1998) (11)
Drug therapy of reflux oesophagitis: an update. (1989) (11)
Does the stomach adapt to Helicobacter pylori? (1992) (11)
Endoscopic biliopancreatic balloon dilation. (1996) (10)
Future potential applicability of sucralfate in gastroenterology. (1990) (10)
Management in peptic ulcer hemorrhage: a Dutch national inquiry. (2000) (10)
Technicalities of endoscopic biopsy. (1995) (10)
Helicobacter pylori eradication and reinfection (1995) (10)
Colloidal bismuth subcitrate in peptic ulcer disease. (1986) (10)
Helicobacter pylori—reflections for the next millennium (1999) (10)
helicobacter pylori: a workshop review (1993) (10)
Long-term GERD management: the individualized approach. (2006) (10)
Possibilities and Shortcomings of Maintenance Therapy in Gastroesophageal Reflux Disease (1999) (10)
Examination of small bowel enzymes in chronic diarrhea (2003) (9)
Crohn's disease of the colon. Analysis of the diagnostic value of radiology, endoscopy, and histology. (1976) (9)
Inflammatory bowel disease and the genes for the natural resistance-associated macrophage protein-1 and the interferon-gamma receptor 1. (1999) (9)
Helicobacter Infection in Man: Problems to Be Solved (1998) (9)
Heterogeneity of human biliary mucin: functional implications. (1994) (9)
Endoscopic gastritis and duodenitis. (1992) (9)
A physician with a positive hepatitis C virus RNA test after a needlestick injury. (2003) (9)
Early gastric stump cancer: macroscopic and microscopic appearance. (1989) (9)
Campylobacter pylori. Diagnosis and treatment. (1989) (8)
In situ detection of interleukin-1 beta and interleukin 8 in biopsy specimens from patients with ulcerative colitis. (1995) (8)
Antral G-cell hyperplasia: a vanishing disease? (1995) (8)
Observer agreement in endoscopic assessment of ulcerative colitis (2001) (8)
Early gastric cancer and intestinal metaplasia (1991) (8)
Gastric endocrine cells (2003) (8)
Letter: Loperamide and ileostomy output. (1975) (8)
Current Concepts in the Management of Helicobacter pylori Infection - The Maastricht 2-2000 Consensus Report (Updated Contents) (2004) (8)
Role of Surveillance in Intestinal Metaplasia of the Esophagus and Gastroesophageal Junction (2003) (8)
PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (1996) (8)
The role of Campylobacter pylori in gastroduodenal diseases. A "believer"'s point of view. (1989) (7)
Value of coloscopy in the detection of sigmoid malignancy in patients with diverticular disease. (1977) (7)
Aspects of anti- Helicobacter pylori eradication therapy (1996) (7)
Pentasa in lieu of sulfasalazine. (1988) (7)
Concanavalin A-binding cholesterol crystallization inhibiting and promoting activity in bile from patients with Crohn's disease compared to patients with ulcerative colitis. (1999) (7)
Does Helicobacter pylori infection influence response rate or speed of symptom control in patients with gastroesophageal reflux disease treated with rabeprazole? (2006) (7)
Campylobacter pylori: epidemiological considerations. (1989) (6)
Effect of phenolphthalein on the function and structure of rodent and human intestine (1978) (6)
A patient with hereditary hemochromatosis, ulcerative colitis, and primary sclerosing cholangitis: genetic aspects. (2001) (6)
"4C-urea breath test inCpylori gastritis (1989) (6)
Short report: evaluation of Helicobacter pylori eradication with bismuth sucrlfate (1994) (6)
TREATMENT OF FAECAL INCONTINENCE IN A CHILD WITH SACRAL AGENESIS: THE USE OF BIOFEEDBACK TRAINING (1994) (6)
Five-year cimetidine maintenance trial for peptic ulcer disease. A clinical and endocrinologic approach. (1990) (6)
Barrett's esophagus: is it all that bad? (1999) (6)
Significance of Campylobacter pylori (1987) (6)
Review article: Practical management issues for the Helicobacter pylori-infected patient at risk of gastric cancer. (1998) (5)
Helicobacter pylori eradication therapy in The Netherlands. (1999) (5)
Consequences of gastric surgery for benign conditions: an overview. (1988) (5)
Inflammatory Bowel Disease – Aspects of Differential Diagnosis (1986) (5)
Cholesterol gallstone growth in model biles is inversely related to cholesterol crystal formation (1998) (5)
Clinical efficacy of sucralfate in reflux oesophagitis. (1987) (4)
Experience with 14C-Urea Breath Test in Detecting Campylobacter pylori (1988) (4)
Reflections on the future of gastroenterology--unmet needs. (2007) (4)
Analysis of a positional candidate gene for imflammatory bowel disease: NRAMP2 (2000) (4)
Helicobacter pylori gastritis - a global view (2000) (4)
The drug treatment of crohn’s disease (1986) (4)
HELICOBACTER PYLORI, GASTRITIS AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (1997) (4)
Effects of Mg++ and Ca++ on water absorption from rodent and human intestine. (1981) (4)
Peritoneal dialysis is associated with an increased incidence of acute pancreatitis but hemodialysis is not (1998) (4)
Campylobacter pylori, gastritis and peptic ulcer disease (1988) (4)
Interaction of cholesterol-crystallization-promoting proteins with vesicles. (1995) (4)
A young female with a cholangiocarcinoma in the past: is pregnancy allowed? (1996) (4)
Colonoscopy in Inflammatory Bowel Disease (1982) (4)
The clinical use of cisapride in gastro-oesophageal reflux disease, with particular focus on the long-term treatment aspects. (1995) (4)
Important acquisitions in Helicobacter pylori infection (1995) (4)
GALLBLADDER MUCIN AND CHOLESTEROL GALLSTONES (1993) (4)
Ulcers and gastritis. (1998) (3)
Molecular alterations in early gastric carcinomas: no apparent correlation with H. pylori status (1998) (3)
Oesophageal intestinal metaplasia. (2000) (3)
Intestinal conditions mimicking Crohn's disease. (1998) (3)
Helicobacter pylori in intensive care (2004) (3)
Helicobacter pylori -associated gastric cancer: is population-based screening and therapy realistic? (1998) (3)
Role of Helicobacter pylori infection in gastro-oesophageal reflux disease (1996) (3)
Endoscopist's view of the future role of the gastroenterologist in digestive oncology (2013) (3)
Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland (1992) (3)
Incidence of cancer in esophageal columnar metaplasia (Barrett’s esophagus) (1992) (3)
Discussion on antro-fundic dysfunction in functional dyspepsia. (2004) (3)
Global view of helicobacter pylori associated gastritis (2000) (3)
Crohn's disease of the colon (1976) (3)
Auto‐immune granulocytopenia, possibly associated with levamisole therapy (1980) (3)
Loss of E‐cadherin expression in gastric carcinogenesis (1998) (2)
Pancreatic polyethylene stents are blocked by a proteinaceous matrix (1995) (2)
The clinical significance of Helicobacter pylori infection in chronic dyspepsia and peptic ulcer disease. (1991) (2)
Modern diagnostic evaluation and preoperative staging of esophageal cancer. (1993) (2)
Gastro Update Europe 2018 (2019) (2)
Acute gastrointestinal bleeding. (2008) (2)
Aetiology of Ischaemic Colitis (1984) (2)
Is Helicobacter pylori associated with gastrointestinal bleeding after cardiac surgery? (2000) (2)
Impaired drinking capacity in dysmotility-like functional dyspeptic patients (1999) (2)
Treatment of Peptic Ulcer Disease with Bismuth Preparations (1988) (2)
Functional dyspepsia. (1995) (2)
Future Clinical Development of Sucralfate (1995) (2)
Cytokine Induction in Experimental and Ulcerative Colitis (1992) (2)
Precancerous lesions of the digestive tract: The 18th Annual Symposium of the European Cancer Prevention Organisation Maastricht, The Netherlands, 12-14 October 2000 (2000) (2)
Probable ischemic proctosigmoiditis presenting 8 weeks post-partum. (1993) (2)
Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease. (1987) (2)
Reflections on gastric ulcer disease (1996) (2)
Helicobacter pylori (1998) (2)
Use of buffered formaldehyde in the enzymatic digestion of inflamed mucosa. (1996) (2)
Helicobacter pylori: recent developments. (1994) (2)
Bismuth is better. (1988) (1)
Natural History and Long-Term Monitoring of Therapeutic Attempts to Eradicate Helicobacter pylori (1990) (1)
La coloscopie dans le diagnostic de la colite ischémique: Résultats de la surveillance de 39 patients (1985) (1)
Semiquantitative Histopathology of Active Chronic Gastritis in Campylobacter pylori Infection and Its Relationship to Peptic Ulcer Disease and Gastric Carcinoma (1988) (1)
Attempts to Eradicate Campylobacter pylori — Dutch Experiences (1988) (1)
How to detect Helicobacter pylori infection in the critically ill patient? (2000) (1)
Antimicrobial susceptibility of Helicobacter pylori in Amsterdam in the last 10 years (2000) (1)
Does histology predict clinical relapse in ulcerative colitis (2001) (1)
Literature and References (1984) (1)
Histopathology of Ischaemic Colitis (1984) (1)
Intralipid-induced gastric relaxation in humans is mediated by nitric oxide (2001) (1)
Altered phospholipids inhumanrheumatoid synoviocytes B.HENDERSON, L.BITENSKY, AND J.CHAYENpage24 Ankylosing spondylitis andinflammatory boweldisease I.Prevalence ofinflammatory boweldisease inpatients suffering fromankylosing spondylitis (1978) (1)
Oesophageal disorders and gastro-oesophageal reflux disease. (1999) (1)
Relevance of VacA and Mucosal Pathological Changes among Chinese Patients with Upper Gastrointestinal Diseases after Helicobacter pylori Eradication (2002) (1)
Lack of association between vacA subtypes and disease in Helicobacter pylori-infected patients from the Netherlands (1998) (1)
[Is the operated stomach a precancerous condition?]. (1983) (1)
Radiological Aspects in Diagnosis of Ischaemic Colitis (1984) (1)
Contributions of the molecular biologist in gastrointestinal cancer and precancer screening: current possibilities and future prospects. (1997) (1)
Diagnosis of Helicobacter pylori infection. (1996) (1)
[Carcinoma with premalignant changes in stomach biopsies of patients having undergone a stomach operation more than 15 years ago]. (1984) (1)
Biliopancreatic malignancy: from gene to cure: 1999 Febr 4-6, AMC, Amsterdam: eds (1999) (1)
Immunohistological Evidence for Mycobacteria in Crohn’s Disease (1992) (1)
Gastro-entero-hepatology in the next millennium. (1997) (1)
Peptic Ulcer Bleeding, NSAID Use and Helicobacter Pylori Infection: A Prospective Study Evaluating Prevalence and Outcome (2004) (1)
Ph monitoring and treatment of gastroesophageal reflux disease (1995) (1)
Adhesion Properties of Helicobacter pylori (1991) (1)
Lexipafant (BB882), a platelet-activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis (1996) (1)
Role of CCKa-receptors in post-prandial LES function in morbidly obese subjects (2001) (1)
Reflections on esophageal columnar metaplasia (Barrett)‐ANNO 2015 (2015) (1)
Oral S(+)ketamine increases visceral sensitivity in healthy volunteers (2003) (1)
Helicobacter pylori infection and duodenal ulcer (1991) (1)
Sucralfate. Role of endogenous sulfhydryls and basic fibroblast growth factor (bFGF). (1995) (1)
Lack of effect of fundic relaxation on the drinking capacity and symptoms after a drink test in healthy volunteers and functional dyspeptics (2000) (1)
Nicotinic receptor blocking effect of guanethidine (1998) (1)
Fata eosinophilic enteritis. (1976) (1)
[Pharmacotherapeutic compass 1998]. (1998) (0)
Highlights from Gastro Update Europe - Prague, June 2018. (2018) (0)
Reply (1994) (0)
Involvement of VIP1 receptors in surgery-induced relaxation of the rat gastric fundus (2000) (0)
[Is the resected stomach a premalignant condition?]. (1983) (0)
Autoimmune pancreatitis: a novel disease? (2012) (0)
Mechanisms of cholesterol gallstone formation. (1995) (0)
CHAPTERR 4 HelicobacterHelicobacter pylori-assoc\ateó Gastric Diseases Andd Lymphoid tissue hyperplasia inn Gastric Antral Mucosa (2007) (0)
Conferencia magistral gastric MALT-lymphoma. (2003) (0)
Pharmacological modulation of the acute phase response in experimental colitis (1994) (0)
Longterm results of pneumatic dilation in achalasia (2000) (0)
Highlights from Gastro Update Europe: Budapest, June 12-13, 2015. (2015) (0)
UvA-DARE ( Digital Academic Repository ) In vivo signal transduction : mitogen activated protein kinases in inflammation (2007) (0)
Involvement of nitric oxide in human primary esophageal peristalsis (1998) (0)
11-dehydro-thromboxane B2 enzyme immuno assay, a suitable screening assay for aspirin use? (2001) (0)
[Electron microscopic findings during treatment of Campylobacter pylori-positive gastritis with bismuth salts]. (1987) (0)
Use of PCR and DNA hybridization in determining CAGA among Helicobacter pylori isolates from peptic ulcer and non ulcer patients (1995) (0)
[The role of cytokines in the pathogenesis of inflammatory intestinal diseases]. (1994) (0)
Risk of cancer after remote peptic ulcer surgery (1990) (0)
[The value of sigmoido-colonoscopy compared with recto-colonic radiography]. (1972) (0)
Gaining a European perspective (2000) (0)
GORD: long-term treatment with a proton pump inhibitor compared with operation. (2002) (0)
Initial experience with sigmoido-coloscopy. (1972) (0)
Involvement of glutamate in transient lower esophageal sphincler relaxation in man (2001) (0)
[Gastro-highlights 2012]. (2013) (0)
CHAPTERR 5 Relevanc ee of VacA and mucosa l pathologica l change s inn Chines e patient s wit h gastroduodena l disease s afterr Helicobacter pylori eradicatio n (2007) (0)
Biliopancreatic endoscopy prof. Marco Bruno - Gastro update Europe 2019, Budapest (2020) (0)
4702 National survey of management in peptic ulcer hemorrhage. (2000) (0)
Role of the proximal stomach in the generation of postprandial symptoms in functional dyspepsia (2001) (0)
Triggering of rapidly propagating phase III-like activity by high dosage of L-NMMA (2000) (0)
Comparison between gastric barostat and SPECT scanning to detect gastric relaxation (2003) (0)
Helicobacter pylori : basic mechanisms to clinical cure : proceedings of the international symposium held at Amelia Island, Florida, USA, November 3-6, 1993 (1994) (0)
The hidden challenge of dyspepsia and heartburn : Is the world united? : Satellite symposium to the 11th World Congress of Gastroenterology, 8 September 1998, Vienna, Austria (1999) (0)
Helicobacter pylori : basic mechanisms to clinical cure, 1998 : the proceedings of a symposium (1998) (0)
Significance of helicobacter pylori discovery for medicine: editorial (1999) (0)
14C-urea breath test as a method to detect Campylobacter pylori colonization. (1989) (0)
Highlights from Gastro Update Europe - Prague, April 29-30, 2016. (2016) (0)
Endoscopic and Histologic Aspects of Gastritis (1990) (0)
[Mortality from stomach carcinoma following stomach surgery for benign disorders; analysis of an Amsterdam cohort]. (1988) (0)
Radiological Aspects of Ischaemic Colitis (1984) (0)
Reply (1995) (0)
Expression of sonic hedgehog in the human and mouse stomach, a possible as a gastric epithelial morphostal (2001) (0)
O.58 Impaired biliary lipid secretion in critically illpatients (1997) (0)
The most optimal duration of H. pylori eradication therapy for patients with ulcer disease in general practice: A four days triple therapy (2000) (0)
Pharmacology of laxatives (1977) (0)
Helicobacter pylori: controversial and unsolved issues. (1996) (0)
Novel developments in endoscopy of the proximal :GIT Oliver Pech (Germany) - Gastro Update Europe 2018, Prague (2018) (0)
Correspondence (1989) (0)
An immunohistochemical study on the relation between cholecystokinin and nitric oxide synthase in the rat brain stem (2001) (0)
Highlights from Gastro Update Europe - Vienna April 6-8, 2017. (2017) (0)
Endoscopy in Diagnosis of Ischaemic Colitis (1984) (0)
[The value of coloscopy in patients with radiological findings of sigmoid disorders]. (1977) (0)
III Critical Review of the Diagnosis of Columnar Metaplasia in the Esophagus and the Esophagogastric Junction : the Paris Workshop * (2005) (0)
Management in peptic ulcer hemorrhage: a national inquiry (1999) (0)
Endoscopic screeningformalignancy inthegastric remnant:theclinical significance ofdysplasia in gastric mucosa (1984) (0)
Therapeutic Methods for Ischaemic Colitis (1984) (0)
Increased levels of gut homing ILA-secreting lymphocytes in inflammatory bowel disease (1996) (0)
Chapter 6 HELICOBACTER PYLORI INFECTION BUT NOT SEVERITY OF DISEASE DETERMINES GASTRIC PERMEABILITY IN CRITICALLY ILL PATIENTS (2012) (0)
5th Educational Training Workshop in helicobacter pylori-management of helicobacter pylori infected patients, 24 October 1998, Bologna, Italy : editors, A T R Axon, G N J Tytgat, guest editors, M. Miglioli, V. Stanghellini, D. Vaira, R M Genta, R Corinaldesi (1999) (0)
The anti-inflammatory effect of interleukin-10 in a rabbit model of colitis (1996) (0)
A physician with a positive HCV-RNA test after a needle stick injury. (2003) (0)
Growth of human gallstones in gallbladder bile of IBD and gallstone patients (1999) (0)
M. Gg10241-De Vree (1999) (0)
[Histologic, culture and breath test detection methods and therapy of Campylobacter pylori colonization of the stomach]. (1987) (0)
Conference proceedings, biliopancreatic malignancy : from gene to cure, 4-6 February 1999- Academic Medical Centter, Amsterdam, the Netherland (1999) (0)
Foreword (2006) (0)
Induction of IL-8 in Inflammatory Bowel Disease (1993) (0)
Gastro Update Europe 2020. (2021) (0)
Panel Discussion: What is New in Etiology and Pathogenesis of Peptic Ulcer Disease? (1988) (0)
antagonist Cholinesterase inhibitor ↑ ↑ Levosulpiride D 2 antagonist ↑ ↓ ↑ Erythromycin Motilin agonist ↑ ↑ ↑ ↓ (2021) (0)
Nitric oxide - a new neurotransmitter in the gastrointestinal tract (1997) (0)
Gene therapy for cholangiocarcinoma using adenovirus vectors expressing the apoptosis-inducing protein Apoptin (1999) (0)
Evaluation ofthePerformance ofCommercial TestKitsfor Detection ofHelicobacterpylo ri (1992) (0)
Lactase Deficiency (1975) (0)
Ulcers and gastritis. (2000) (0)
HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER. AUTHOR'S REPLIES (1991) (0)
Highlights from Gastro Update Europe - Budapest June 26-27, 2019. (2019) (0)
99. TPN in critically ill patients: the influence on bile secretion (1997) (0)
UvA-DARE ( Digital Academic Repository ) CD 4 antibody treatment in patients with active Crohn ' s disease : a phase 1 dose finding study (1998) (0)
9th Meeting of the European Association for the Study of the Liver (Part 4 of 4) (1974) (0)
Discrepancies and pitfalls in diagnosis and therapy of esophageal columnar metaplasia/Barrett's esophagus: A personal view (2013) (0)
Pneumatic dilatation as treatment for achalasia: long-term follow-up of more than 15 years (1999) (0)
The hidden challenge of dyspepsia and heartburn: Is the world united? Summary and closing comments: key agenda for the coming years. (1999) (0)
Helicobacter Pylori 1990: Proceedings of the Second International Symposium on Helicobacter Pylori Bad Nauheim, August 25 26th, 1989 (1991) (0)
Pathogenesis of H. pylory-associated duodenal ulcer disease. (2003) (0)
Relationship with disease of caga positive H. pylori in primary care patients of different ethnic origin (2000) (0)
[Is there an endobrachy-esophagus cancer sequence?]. (1990) (0)
Original ContributionsRelation between vacA subtypes, cytotoxin activity, and disease in Helicobacter pylori-infected patients from the netherlands (1999) (0)
Novel developments in intestinal Endoscopy prof. Oliver Pech - Gastro update Europe 2019, Budapest (2020) (0)
Symposium on campylobacter pylori (1987) (0)
Is there a role for interferon-a monotherapy in HBsAg and anti-HBe positive chronic hepatitis B? (1999) (0)
De-Nol: Mucosal Protection and Peptic Ulcer Disease: De-Nol Symposium, 8th World Congress of Gastroenterology, So Paulo, September 1986: Proceedings (1987) (0)
functions in healthy subjects Role of nitric oxide in gastric motor and sensory (2006) (0)
Gastro Update Europe 2020 (2021) (0)
UvA-DARE (Digital Academic Repository) Equally high prevelance of infection with cagA- positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia (1997) (0)
8th Meeting of the European Association for the Study of the Liver (1973) (0)
Vasculature of the Colon (1984) (0)
Management of Helicobacter pylori infected patients [guest editors] (2000) (0)
Mortality caused bystomach cancerafter remote partial gastrectomy forbenign conditions: 40yearsof follow up ofanAmsterdam cohort of2633 postgastrectomy patients (1988) (0)
The influence of the resection of affected intestinal segments on specific mycobacterial antibodies in crohns disease (1991) (0)
L’histoire duCampylobacter pylori (1987) (0)
Time course of acid inhibition by P-CABs and PPIs : computer simulation ( 2 ) (2020) (0)
Gastricc Endocrine cells (2007) (0)
UvA-DARE ( Digital Academic Repository ) Pathogenesis of gallstones in Crohn ' s disease (2012) (0)
The Future of Acid Inhibition (2011) (0)
Differential Diagnosis of Ischaemic Colitis, Ulcerative Colitis and Crohn’s Disease of the Colon (1984) (0)
9th Meeting of the European Association for the Study of the Liver (Part 2 of 4) (1974) (0)
infection Helicobacter pylori Regular review: Treatment of (2006) (0)
Intestinal metaplasia of the oesophagus and oesophagogastric junction (1999) (0)
Antimicrobiol prophylaxis and therapy (2005) (0)
Peptic ulcer disease. (2000) (0)
RESULTS OF A DUTCH QUESTIONNAIRE ON HAEMOSTASIS IN GASTRO-ENTEROLOGY AND LIVER DISEASE. Part I: Liver disease (1988) (0)
Helicobacter pylori: recent developments. (1995) (0)
Evidence illustrating the need for dysplasia screening in patients with longstanding achalasia (2006) (0)
Other Diagnostic Procedures (1984) (0)
Classification of Ischaemic Colitis (1984) (0)
Haplotype of the interleukin-1 gene locus is associated with ulcerative colitis (1999) (0)
Clinical role of the stool antigen test in predicting failed eradication shortly after completion of therapy (2000) (0)
Genetic variation in Helicobacter pylori (2012) (0)
Effect of L-NMMA on proximal stomach function in healthy volunteers (2000) (0)
Gastro Update Europe 2020 : Meeting report of Gastro Update Europe 2020, September 4-5, 2020 (2021) (0)
Immunotherapeutical Approaches to Crohn’s Disease in View of a Possible Pathogenic Role of Mycobacterial Antigens (1992) (0)
Altered expression of alfa4beta7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation Meenan, (1998) (0)
Variations in the Incidence of Ischaemic Colitis with Age and Sex of the Patient (1984) (0)
[Evaluation of endoscopy with biopsy in malignant tumors of the upper part of the digestive tract]. (1973) (0)
Endoscopic Examination of the Small Bowel in Idiopathic Inflammatory Bowel Diseases (1990) (0)
Variations in the Incidence of Ischaemic Colitis with Age and Sex of the Patients Studied in the Literature (1984) (0)
Dextremetherphan, a N-methyl-D-asparate-receptor antagonist, Induces increased sensitivity to gastric distention in healthy volunteers (2001) (0)
Novel large bowel developments prof. Jaroslaw Regula - Gastro update Europe 2019, Budapest (2020) (0)
Helicobacter pylori and Epstein-Barr virus infection and the p 53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated (0)
HELICOBACTER PYLORI INFECTION BUT NOT SEVERITY OF DISEASE DETERMINES GASTRIC PERMEABILITY IN CRITICALLY ILL PATIENTS (1999) (0)
Endosonography in gastroenterology. Preface. (2009) (0)
Novel developments in small bowel diseases and intestinal microbiota Sherine Khater (France) -Gastro Update Europe 2018, Prague (2018) (0)
Anatomical Distribution of Ischaemic Colitis (1984) (0)
[The significance of Helicobacter pylori in medical science]. (1998) (0)
Cholesterol nucleation promoting lipoprotein binds cholesterol and lecithin (1991) (0)
Higlights from Gastro Update Europe 2019 (2019) (0)
Esophageal endoprosthesis in malignant stricture. (1994) (0)
Gastro Update Europe 2020 (2021) (0)
Pathophysiology of Ischaemic Colitis (1984) (0)
Highlights from Gastro Update Europe 2019: Budapest, June 14–16 (2019) (0)
Announcements (1957) (0)
9th Meeting of the European Association for the Study of the Liver (Part 1 of 4) (1974) (0)
Quality of life and hepato-biliary related symptoms before and after endoscopic removal of bile duct stones (BDS): A randomized trial comparing endoscopic balloon dilatation of the biliary sphincter (EBD) and endoscopic sphincterotomy (EST) (1997) (0)
Esophageal endoprosthesis in malignant stricture. (1994) (0)
Classification and Definitions of the Different Forms of Ischaemic Colitis (1984) (0)
Endoscopic diagnosis of esophageal columnar metaplasia or Barrett's esophagus (2006) (0)
Prolonged intragastric distention in humans induces phasic gastric contractions during fasting and after a meal (2000) (0)
RESULTS OF A DUTCH QUESTIONNAIRE ON HAEMOSTASIS IN GASTRO-ENTEROLOGY AND LIVER DISEASE. Part II: Gastro-enterology (1988) (0)
No evidence for functional inactivation of wild-type p53 protein by MDM-2 overexpression in gastric carcinogenesis: an immunohistochemical study (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Guido N. J. Tytgat?

Guido N. J. Tytgat is affiliated with the following schools:

University of Amsterdam